US FDA And Congress: Criticism Of Leadership Ramping Up, But Bipartisan Truce Holds For Now

Senate Finance Committee’s hearing on FDA’s overseas inspection program suggests that agency’s status as a rare focus for bipartisan support amid the Trump Presidency is getting more tenuous – but still holding for the time being.